This week's Fierce Biotech Research is brought to you by Lonza.

Complimentary White Paper Download

Hi E, check out this Fierce White Paper we think you'll like:

A focus on cell line development: Accelerating antibody DNA to IND timelines without negatively impacting quality

Novel antibody-based therapeutics have revolutionized healthcare and are a prominent feature on top-selling pharmaceutical lists. As antibody engineering and manufacturing technologies improve, previously untreatable diseases can be targeted with increased speed and efficiency. Creating a pathway that balances cost, speed and risk for therapeutic antibody development is crucial to successful and timely approval of new therapeutics. 

In this whitepaper, discover how to:  

• Keep up with an evolving market 
• Optimize cell line development workflow  
• Harness cell pools for accelerated program design